SLC-0111
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SLC-0111, covering 2016-05-17 to 2024-05-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX [Phase 1, Phase 2]